Carlos Levi D'Ancona
Alex Tong-Long Lin
#31 Computational fluid dynamics simulation of male voiding: a novel method using real-time magnetic resonance image
PRIZE AWARD: Best Video Abstract
Soh S1, Iwahata T1, Suzuki K1, Shimomura Y1, Kobayashi T1, Sadaoka Y1, Ashizawa Y1, Shin T1, Kobori Y1, Yagi H1, Arai G1, Okada H11. Dokkyo Medical University Koshigaya Hospital
Anatomy, Male, Imaging, Urodynamics Techniques, Pathophysiology
#32 Flow time and voiding time – definitions and use in identifying detrusor underactivity
Gammie A1, Yoshida S2, Steup A2, Kaper M2, Dorrepaal C2, Kos T2, Abrams P11. Bristol Urological Institute, 2. Astellas Pharma Europe B.V.
Underactive Bladder, Urodynamics Equipment, Urodynamics Techniques
#33 Compensation mechanism in bladder outlet obstruction (BOO) – thinking outside the box
Alloussi S H1, Schnabel S1, Bleser T2, Alsfasser A1, Alloussi S11. Diakonie Klinikum Neunkirchen, 2. Winterberg Klinikum Saarbrücken
Bladder Outlet Obstruction , Detrusor Hypocontractility, Detrusor Overactivity
#34 International Continence Society definition of detrusor underactivity; analysis of clinical parameters and comparison with contractility grading methods
ten Donkelaar C1, Rosier P1, de Kort L11. University Medical Center Utrecht
Detrusor Hypocontractility, Male, Retrospective Study, Underactive Bladder, Voiding Dysfunction
#35 Are LUTS an independent indicator of cardiovascular disease (CVD) development? A cross-sectional and longitudinal analysis in middle-aged to elderly men
Martin S1, Vincent A1, Adams R1, Taylor A1, O'Louglin P2, Wittert G11. University of Adelaide, 2. SA Pathology
Male, Prospective Study, Voiding Dysfunction
#36 A combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Suzuki T1, Otsuka A1, Ozono S11. Hamamatsu University School of Medicine
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Male
#37 What is the additional burden for patients with detrusor underactivity when they also have detrusor overactivity?
Abrams P1, Gammie A1, Yoshida S2, Steup A2, Kaper M3, Dorrepaal C3, Kos T21. Bristol Urological Institute, 2. Astellas Pharma Europe B.V., 3. Astellas Pharma Europe B.V
Underactive Bladder, Detrusor Overactivity, Detrusor Hypocontractility, Overactive Bladder
#38 Discontinuation of alpha-blocker therapy in male lower urinary tract symptoms: a systematic review
Hordijk I1, Korteschiel L2, Steffens M2, Lisman-van Leeuwen Y1, Blanker M11. University Medical Center Groningen, department of General Practice, 2. Isala Clinics, department of urology
Male, Benign Prostatic Hyperplasia (BPH), Clinical Trial, Voiding Dysfunction
#39 Prescription patterns of alpha-blockers for male Lower Urinary Tract Symptoms in Dutch men.
Hordijk I1, Blanker M1, Hak E21. University Medical Center Groningen, department of General Practice, 2. University of Groningen, Groningen Research Institute of Pharmacy
Benign Prostatic Hyperplasia (BPH), Conservative Treatment, Male
#40 Combination of solifenacin with tamsulosin but not tamsulosin affects morphometric and functional parameters of the prostate in patients with benign prostate enlargement (BPE) and overactive bladder (OAB). Results from a randomized pilot study.
Sakalis V1, Sfiggas V1, Vouros I1, Salpiggidis G1, Papathanasiou A1, Apostolidis A21. Department of Urology, Ippokration Hospital, Thessaloniki, Greece, 2. 2nd Department of Urology, Aristotle University of Thessaloniki, Greece
Benign Prostatic Hyperplasia (BPH), Detrusor Overactivity, Overactive Bladder, Pharmacology, Pathophysiology
#41 Therapeutic efficacy and safety of mirabegron monotherapy in male overactive bladder patients with and without bladder outlet obstruction
Liao C1, Lee C2, Lee Y2, Kuo H21. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Bladder Outlet Obstruction , Pharmacology, Clinical Trial
#42 Men undergoing transurethral prostate surgery (TURP) for acute urinary retention (AUR) tied to earlier death.
Chan C1, Ng C1, Chan S1, Chiu P K F2, Yee S C H1, Wong J H M1, Teoh J Y C3, Yuen S K K4, Hou S M41. SH Ho Urology Centre, Division of Urology, Dept. of Surgery, The Chinese University of Hong Kong, 2. SH Ho Urology Centre, Division of Urology, Dept. of Surgery, The Chinese Univerisity of Hong Kong, 3. SH Ho Urology Centre, Division of Urology, Dept of Surgery, The Chinese University of Hong Kong, 4. SH Ho Urology Centre, Division of Urology, Department of Surgery, The Chinese University of Hong Kong
Surgery, Benign Prostatic Hyperplasia (BPH), Gerontology, Male, Retrospective Study